Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nightingale HealthNGHLF 67 EV-to-EBITDA is -1.25 as of Aug. 06, 2026. GuruFocus rates NGHLF with a GF Score™ of 67/100 and a GF Value™ of $4.61. The stock has 6 warning signs investors should review. Among 508 Healthcare Providers & Services companies, Nightingale Health ranks worse than 196850.2% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Nightingale Health's enterprise value is $15.45 Mil.
Nightingale Health's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $-12.35 Mil. Therefore, Nightingale Health's EV-to-EBITDA for today is -1.25.
The historical rank and industry rank for Nightingale Health's EV-to-EBITDA or its related term are showing as below:
NGHLF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -82.71 Med: -4.42 Max: 3.02
Current: -1.11
During the past 7 years, the highest EV-to-EBITDA of Nightingale Health was 3.02. The lowest was -82.71. And the median was -4.42.
NGHLF's EV-to-EBITDA is ranked worse than 100% of 508
companies
in the Healthcare Providers & Services industry
Industry Median: 11.015
vs NGHLF: -1.11
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Nightingale Health (OTCPK:NGHLF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Nightingale Health's PE Ratio (TTM) for today is calculated as:
Nightingale Health's share price for today is $1.19.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nightingale Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.372.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Nightingale Health's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Nightingale Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nightingale Health EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nightingale Health's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Nightingale Health's EV-to-EBITDA falls into.
Nightingale Health's current Enterprise Value is $15.45 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nightingale Health's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $-12.35 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nightingale Health (NGHLF) has a EV-to-EBITDA of -1.25 as of Aug. 06, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Nightingale Health. According to the industry distribution chart, Nightingale Health ranks #999999 out of 508 companies in the Healthcare Providers & Services industry.
Is Nightingale Health's EV-to-EBITDA too high?
Nightingale Health's current EV-to-EBITDA is -1.25. Based on the distribution chart, Nightingale Health ranks #999999 out of 508 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Nightingale Health has a GF Score™ of 67/100, reflecting its overall financial health beyond just this single metric.
How does Nightingale Health's EV-to-EBITDA compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Nightingale Health ranks #999999 out of 508 companies for EV-to-EBITDA. This places Nightingale Health in the lower half of its industry. The industry median EV-to-EBITDA is 11.02. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 11.02, based on 508 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Nightingale Health. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 11.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nightingale Health's current EV-to-EBITDA is -1.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nightingale Health stock overvalued right now?
Nightingale Health (NGHLF) has a current EV-to-EBITDA of -1.25. The stock's GF Value™ is $4.61, compared to a current price of $1.19 — trading 74.2% below its estimated fair value. The current EV-to-EBITDA is -1.25. Nightingale Health's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Nightingale Health (NGHLF), the current EV-to-EBITDA is -1.25 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nightingale Health (NGHLF) Overvalued in 2026?
Based on GuruFocus' analysis, Nightingale Health stock appears to be undervalued.
The current stock price of $1.19 is trading 74.2% below its estimated GF Value™ of $4.61.
Key valuation signals for NGHLF:
EV-to-EBITDA: -1.25
GF Value™: $4.61 vs. price of $1.19 (74.2% below fair value)
No single metric tells the full story. See the NGHLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nightingale Health PLC offers a health data platform that detects disease risks. The Health Data Platform empowers individuals to take actions to prevent diseases by allowing them access to disease risk information. With its Health Data Platform, the company connects the services of healthcare actors with the preventative health needs of individuals. The company operates in Finland, Japan, the United Kingdom, Singapore, and the USA.
67GF Score
Get the complete analysis for NGHLF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NGHLF has been successfully added to your 
